Theravance Biopharma Inc TBPH

NASDAQ · United States · Health Technology

$17.030.00 (0.00%)

Market open· Sep 23, 2026, 8:00 PM UTC· USD · Data may be delayed

This stock no longer appears on its exchange. It may have been delisted, merged into another company or taken private. The figures below are the last ones we have.

Prices may be delayed and are for informational purposes only - not investment advice.

Makkler App

Faster and clearer

Install

Theravance Biopharma Inc TBPH

NASDAQ · United States · Health Technology

$17.030.00 (0.00%)

Market open· Sep 23, 2026, 8:00 PM UTC· USD · Data may be delayed

This stock no longer appears on its exchange. It may have been delisted, merged into another company or taken private. The figures below are the last ones we have.

Prices may be delayed and are for informational purposes only - not investment advice.

0.00% · 6MFull-screen chart

Open $17.03High $17.03Low $17.03Close $17.03Volume 0

Sep 25, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: $17.03
Day range: $17.02 – $17.07
52-week range: $13.08 – $21.03
Volume: 10.02M
Market cap: $884.18M
P/E (TTM): 16.4
Next earnings date: 2026-11-10

Performance

1 week

0.00%

1 month

0.00%

3 months

0.00%

6 months

0.00%

Year to date

0.00%

1 year

0.00%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: United States
Exchange: NASDAQ
IPO date: 2014-05-16
Shares outstanding: 51.92M
Employees: 90
ISIN: KYG8807B1068
Beta: 0.24
Website: www.theravance.com

News

ZacksOct 01, 2026

The Zacks Analyst Blog Highlights First Interstate BancSystem, Southside Bancshares and First Hawaiian

The Motley FoolOct 01, 2026

If I Had $10,000 to Invest Today, Here's the Growth Stock I'd Buy Instead of SpaceX

The Motley FoolOct 01, 2026

Michael Burry's New Bet Against Micron Stock Expires in June 2027. I Think His Timing Is Off.

ZacksOct 01, 2026

Gen Digital (GEN) Soars 5.6%: Is Further Upside Left in the Stock?

Valuation & analysis

Details →

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Theravance Biopharma Inc TBPH

Theravance Biopharma Inc TBPH

Key statistics

Performance

Company profile

News

Technical view

Valuation & analysis